About Cancer Treatment Imbruvica (Ibrutinib)

Imbruvica (Ibrutinib) is an FDA approved targeted therapy treatment for some forms of blood and lymph node cancers, including mantle cell lymphoma and lymphocytic leukemia. Dr. Stephen Lemon, a medical oncologist, talks about how this treatment works, including what types of side effects it may cause patients during treatment. Visit https://www.lightersideofcancer.com/education to watch more cancer education videos.